Exjade Interactions
There are 598 drugs known to interact with Exjade (deferasirox), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 206 are major, 379 are moderate, and 13 are minor.
- View all 598 medications that may interact with Exjade
- View Exjade alcohol/food interactions (2)
- View Exjade disease interactions (6)
Most frequently checked interactions
View interaction reports for Exjade (deferasirox) and the medicines listed below.
- allopurinol
- amitriptyline
- Aranesp (darbepoetin alfa)
- aspirin
- calcium / vitamin d
- CellCept (mycophenolate mofetil)
- cholecalciferol
- Cimzia (certolizumab)
- ciprofloxacin
- Coumadin (warfarin)
- Cymbalta (duloxetine)
- Cytoxan (cyclophosphamide)
- Elaprase (idursulfase)
- Enbrel (etanercept)
- etoposide
- Fabrazyme (agalsidase beta)
- folic acid
- furosemide
- gabapentin
- Gleevec (imatinib)
- hydroxyurea
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- Lasix (furosemide)
- potassium chloride
- prednisone
- Protonix (pantoprazole)
- Tecentriq (atezolizumab)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Exjade alcohol/food interactions
There are 2 alcohol/food interactions with Exjade (deferasirox).
Exjade disease interactions
There are 6 disease interactions with Exjade (deferasirox) which include:
- bone marrow suppression
- dermatologic toxicities
- hepatic impairment
- renal dysfunction
- auditory and ocular abnormalities
- GI complication
Report options
QR code containing a link to this page
More about Exjade (deferasirox)
- Exjade consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: chelating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
